SSKN STRATA SKIN SCIENCES INC revenue, earnings and financials

For the quarter ended December 31, 2025, STRATA SKIN SCIENCES INC reported revenue of $9.29M (down 3.0% from a year earlier), net income of $58.0K and diluted EPS of $0.14; over the last four quarters revenue was $30.7M and net income −$6.26M; for the fiscal year ended December 2025 revenue was $30.7M, down 8.5% on the year before.

SSKN annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $30.7M, gross profit $17.9M, operating income −$4.70M, net income −$6.26M (margin -20.4%), EPS −$1.35
• Fiscal year ended Dec 2024: revenue $33.6M, gross profit $19.2M, operating income −$9.26M, net income −$10.1M (margin -30.1%), EPS −$2.65
• Fiscal year ended Dec 2023: revenue $33.4M, gross profit $18.5M, operating income −$8.60M, net income −$10.8M (margin -32.5%), EPS −$3.10
• Fiscal year ended Dec 2022: revenue $36.2M, gross profit $21.8M, operating income −$4.65M, net income −$5.55M (margin -15.3%), EPS −$0.16
• Fiscal year ended Dec 2021: revenue $30.0M, gross profit $19.9M, operating income −$4.40M, net income −$2.71M (margin -9.0%), EPS n/a

SSKN quarterly revenue and earnings

• Quarter ended Dec 31, 2025 (from the annual report): revenue $9.29M (down 3.0% year over year), net income $58.0K, EPS $0.14
• Quarter ended Sep 30, 2025: revenue $6.93M (down 21.2% year over year), net income −$1.62M, EPS −$0.36
• Quarter ended Jun 30, 2025: revenue $7.66M (down 9.2% year over year), net income −$2.58M, EPS −$0.62
• Quarter ended Mar 31, 2025: revenue $6.81M (up 0.9% year over year), net income −$2.12M, EPS −$0.51
• Quarter ended Dec 31, 2024 (from the annual report): revenue $9.58M (up 10.2% year over year), net income −$4.56M, EPS −$2.01
• Quarter ended Sep 30, 2024: revenue $8.80M (down 0.6% year over year), net income −$2.07M, EPS −$0.51
• Quarter ended Jun 30, 2024: revenue $8.44M (up 2.2% year over year), net income −$91.0K, EPS −$0.03
• Quarter ended Mar 31, 2024: revenue $6.75M (down 10.7% year over year), net income −$3.37M, EPS −$0.10
• Quarter ended Dec 31, 2023 (from the annual report): revenue $8.69M (down 18.0% year over year), net income −$3.79M, EPS −$1.82
• Quarter ended Sep 30, 2023: revenue $8.85M (down 6.0% year over year), net income −$1.05M, EPS −$0.30
• Quarter ended Jun 30, 2023: revenue $8.25M (down 9.4% year over year), net income −$3.15M, EPS −$0.90
• Quarter ended Mar 31, 2023: revenue $7.57M (up 7.5% year over year), net income −$2.84M, EPS −$0.08
• Quarter ended Dec 31, 2022 (from the annual report): revenue $10.6M (up 17.1% year over year), net income −$160K, EPS −$0.01
• Quarter ended Sep 30, 2022: revenue $9.41M (up 22.1% year over year), net income −$995K, EPS −$0.03
• Quarter ended Jun 30, 2022: revenue $9.11M (up 23.3% year over year), net income −$1.89M, EPS −$0.05
• Quarter ended Mar 31, 2022: revenue $7.04M (up 20.8% year over year), net income −$2.50M, EPS −$0.07
• Quarter ended Dec 31, 2021 (from the annual report): revenue $9.06M, net income −$849K, EPS n/a
• Quarter ended Sep 30, 2021: revenue $7.71M, net income −$521K, EPS −$0.02
• Quarter ended Jun 30, 2021: revenue $7.38M, net income $1.08M, EPS $0.03
• Quarter ended Mar 31, 2021: revenue $5.83M, net income −$2.42M, EPS −$0.07

SSKN cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$2.79M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $188K, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$519K, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$924K, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow $1.51M, share buybacks n/a

SSKN balance sheet

• Dec 31, 2025: cash $7.91M, total assets $30.5M, total liabilities $27.6M, shareholders' equity $2.91M, long-term debt $0
• Sep 30, 2025: cash $7.08M, total assets $30.7M, total liabilities $29.4M, shareholders' equity $1.31M, long-term debt $13.4M
• Jun 30, 2025: cash $5.97M, total assets $29.5M, total liabilities $29.0M, shareholders' equity $532K, long-term debt $15.3M
• Mar 31, 2025: cash $6.51M, total assets $33.0M, total liabilities $30.1M, shareholders' equity $2.98M, long-term debt $15.2M
• Dec 31, 2024: cash $7.26M, total assets $34.9M, total liabilities $30.0M, shareholders' equity $4.97M, long-term debt $15.2M
• Sep 30, 2024: cash $7.06M, total assets $39.4M, total liabilities $30.0M, shareholders' equity $9.40M, long-term debt $15.2M
• Jun 30, 2024: cash $5.48M, total assets $38.8M, total liabilities $29.3M, shareholders' equity $9.51M, long-term debt $15.1M
• Mar 31, 2024: cash $5.24M, total assets $39.2M, total liabilities $29.8M, shareholders' equity $9.43M, long-term debt $15.1M

What is SSKN's revenue?

STRATA SKIN SCIENCES INC reported $30.7M of revenue over its last four quarters, through December 31, 2025.

Is SSKN profitable?

No. STRATA SKIN SCIENCES INC lost $6.26M over the last four quarters.

What is SSKN's EPS?

Diluted earnings per share over the last four quarters were −$1.35; $0.14 in the latest quarter.

SSKN ownership and insider trades · All stocks